Renalytix Plc
RENXF
$0.02
-$0.01-35.66%
OTC PK
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.60% | 14.34% | 54.37% | 36.04% | 18.76% |
| Total Depreciation and Amortization | -- | -- | -155.56% | -46.92% | -35.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.16% | -29.19% | -18.72% | 9.66% | -40.88% |
| Change in Net Operating Assets | 124.02% | 913.95% | -24,183.33% | 3,770.00% | -100.93% |
| Cash from Operations | 58.23% | 29.61% | 18.37% | 51.87% | 3.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -160.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 40.00% | -- | -483.33% | 100.00% | -2.04% |
| Issuance of Common Stock | -65.36% | 27,726.09% | 19,767.74% | -75.01% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -56.01% | -- |
| Cash from Financing | -71.29% | 18,595.65% | 3,054.04% | -77.61% | 13.78% |
| Foreign Exchange rate Adjustments | -23.97% | -814.29% | -257.14% | -106.43% | -90.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.89% | 133.15% | 199.99% | -109.93% | -14.51% |